Facebook
Twitter
LinkedIn
Forward
Clinical Insights into Psoriasis in Patients of Color: Bringing New Data to Light
Various gaps in the management of psoriasis in patients with SOC persist due to a lack of training for dermatology practitioners. As a result, patients with SOC are often misdiagnosed, experience more severe disease, and experience more disease burden. Given the predicted increase in the SOC population over the next decades, improving the diagnosis and management of psoriasis in these patients is critical. To improve outcomes in SOC patients with psoriasis, this webcast features esteemed expert dermatologists Mona Shahriari, MD, and Andrew Alexis, MD, MPH engaging in a conversational, expert discussion providing actionable guidance on the clinical presentation, disease burden, clinical and therapeutic nuances of treatment, and strategies to address barriers to care and individualize treatment plans.
Target Audience
This activity is designed for an audience of physicians, nurses, and other advanced practice providers (nurse practitioners/physician assistants) in medical practices that specialize in dermatology.
Learning Objectives
Upon completion of the educational activity, participants should be better able to:
- Describe the clinical presentation and disease burden of psoriasis in SOC patients.
- Summarize clinical updates and nuances of treatment for psoriasis in SOC patients.
- Implement strategies to address patients’ barriers to care and individualize treatment plans.
- Defining "Skin of Color" and Epidemiology of Psoriasis
- Disparities in Care and Clinical Trial Participation
- Case 1 - Assessing Psoriasis in SOC
- Case 2 - Facial Psoriasis
- Case 3 - Scalp Psoriasis
- Case 4 - Post-Inflammatory Pigment Alteration (PIPA)
- Case 5 - Culturally Competent Care
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse
1 ANCC contact hour.
Commercial Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Andrew Alexis, MD, MPH | Advisory board/Consulting | Leo, Galderma, Pfizer, Sanofi-Regeneron, Dermavant, Beiersdorf, Ortho, L’Oreal, BMS, Bausch health, UCB, Vyne , Arcutis, Janssen, Allergan, Almirall, Abbvie, Amgen, VisualDx, Eli Lilly, Swiss American, Cutera, Cara, EPI, Incyte, Castle, Apogee, Canfield, Alphyn |
Researcher | Grants (funds to institution): Leo, Amgen, Galderma, Arcutis, Dermavant, Abbvie, Castle | |
Royalties or patent beneficiary | Royalties | |
Speaker | Regeneron, SANOFI-Genzyme, BMS, L’Oreal, Janssen, J&J | |
Mona Shahriari, MD | Consultant | AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Cara, Dermavant, Incyte, Galderma, Janssen, Leo Pharma, Lilly USA, Novartis, Sanofi-Genzyme, Regeneron, UCB |
Researcher | AbbVie, CorEvitas Psoriasis and Atopic Dermatitis Registry, Dermira, Cara, Dermavant, Novartis, Union, Mindera | |
Speaker | Abbvie, Arcutis, Bristol Myers Squibb, Lilly USA, Janssen, Dermavant, Leo Pharma, Pfizer, Sanofi-Genzyme, Regeneron, UCB | |
Dorothy Caputo, MA, BSN, RN, VP, Healthcare CE and Operations | N/A | Nothing to disclose |
Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
Tarsus dba LiVDerm Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.
AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy)
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.